Ye Fu

Ye Fu is a highly experienced biotechnology professional, currently serving as Chief Technology Officer and Co-Founder of Stellaromics Inc., where innovative technology captures high-resolution 3D multi-omic data from tissue samples. In addition to this role, Ye Fu holds positions as Interim Chief Technology Officer and Board Member at Sedec Therapeutics, focusing on autoimmune and immune-oncology therapeutics, and as a Consultant and Director of Innovation at Aferna Bio, developing technologies for agriculture. Past experience includes serving as Principal at Plaisance Capital Management LLC and conducting postdoctoral research at Harvard University and The University of Chicago, specializing in DNA and RNA modifications and epigenetic studies. Educational credentials include a Bachelor of Science in Chemistry from Peking University and a doctoral degree from the University of Chicago.